QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Reynolds, I. J. Articles by Aizenman, E. Search for Related Content PubMed PubMed Citation Articles by Reynolds, I. J. Articles by Aizenman, E. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB TRYPAN BLUE

 Previous Article  |  Next Article 

Journal of Neuroscience, Vol 12, 970-975, Copyright © 1992 by Society for Neuroscience

ARTICLE

Pentamidine is an N-methyl-D-aspartate receptor antagonist and is neuroprotective in vitro

IJ Reynolds and E Aizenman
Department of Pharmacology, University of Pittsburgh School of Medicine, Pennsylvania 15261.

Acquired immunodeficiency syndrome (AIDS) is frequently associated with dementia. The wide spectrum of neurological abnormalities associated with this dementia may involve a neurotoxin that activates the NMDA subtype of glutamate receptor in neurons. We have found that the antimicrobial agent pentamidine, which is prescribed for AIDS patients for the prophylaxis and treatment of Pneumocystis carinii pneumonia, is an effective NMDA receptor antagonist. Pentamidine inhibited 3H- dizocilpine binding to the NMDA receptor in rat brain membranes at a site separate from glutamate, glycine, and spermidine, with an affinity near 2 microM. Similar concentrations of pentamidine block NMDA-induced increases in intracellular Ca2+ and NMDA-induced currents in cultured forebrain and cortical neurons, apparently without use dependence or voltage dependence, suggesting that pentamidine may represent a novel chemical class of NMDA receptor antagonist. Finally, pentamidine protects neurons from the lethal effects of acute NMDA exposure in vitro. AS pentamidine may accumulate in the brain at relevant concentrations following repeated high-dose parenteral administration, these findings suggest that the drug may be neuroprotective in vivo.

This article has been cited by other articles:

				S. K. Grant, J. G. Sklar, and R. T. Cummings Development of Novel Assays for Proteolytic Enzymes Using Rhodamine-Based Fluorogenic Substrates J Biomol Screen, December 1, 2002; 7(6): 531 - 540. [Abstract] [PDF]

				M. L. Berger and P. Rebernik Zinc and Ifenprodil Allosterically Inhibit Two Separate Polyamine-Sensitive Sites at N-Methyl-D-Aspartate Receptor Complex J. Pharmacol. Exp. Ther., June 1, 1999; 289(3): 1584 - 1591. [Abstract] [Full Text]

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help